(株)カイノスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4556/E00977 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2022/07/01 | 日証協 | 112,900株 | -7.91% | 11,600株 | -3.33% | 160,082株 | -4.59% | 25,926株 | +228.14% |
| 2022/06/24 | 日証協 | 122,600株 | -0.16% | 12,000株 | +900% | 167,780株 | -1.36% | 7,901株 | +315.19% |
| 2022/06/17 | 日証協 | 122,800株 | -4.06% | 1,200株 | -62.5% | 170,100株 | -2.41% | 1,903株 | -23.91% |
| 2022/06/10 | 日証協 | 128,000株 | +1.75% | 3,200株 | -20% | 174,297株 | +0.75% | 2,501株 | +3.26% |
| 2022/06/03 | 日証協 | 125,800株 | -4.41% | 4,000株 | -55.56% | 172,996株 | -2.3% | 2,422株 | -57.51% |
| 2022/05/27 | 日証協 | 131,600株 | +0.53% | 9,000株 | +95.65% | 177,074株 | +0.73% | 5,700株 | +67.6% |
| 2022/05/20 | 日証協 | 130,900株 | +1.24% | 4,600株 | -14.81% | 175,791株 | +0.86% | 3,401株 | -17.19% |
| 2022/05/13 | 日証協 | 129,300株 | -1.67% | 5,400株 | +38.46% | 174,290株 | +0.23% | 4,107株 | +173.44% |
| 2022/05/06 | 日証協 | 131,500株 | +3.22% | 3,900株 | -72.73% | 173,882株 | +0.64% | 1,502株 | -54.51% |
| 2022/04/28 | 日証協 | 127,400株 | -2.08% | 14,300株 | +81.01% | 172,780株 | 0% | 3,302株 | -23.21% |
| 2022/04/22 | 日証協 | 130,100株 | +2.52% | 7,900株 | -30.7% | 172,780株 | +0.47% | 4,300株 | -60.55% |
| 2022/04/15 | 日証協 | 126,900株 | -18.34% | 11,400株 | -21.19% | 171,979株 | -12.07% | 10,901株 | +45.33% |
| 2022/04/08 | 日証協 | 155,400株 | -14.47% | 14,465株 | -72.4% | 195,579株 | -3.69% | 7,501株 | -90.55% |
| 2022/04/01 | 日証協 | 181,700株 | +11.4% | 52,400株 | +24.47% | 203,071株 | +0.65% | 79,400株 | +183.56% |
| 2022/03/25 | 日証協 | 163,100株 | +27.52% | 42,100株 | +5914.29% | 201,750株 | +7.74% | 28,001株 | +1900.07% |
| 2022/03/18 | 日証協 | 127,900株 | -8.64% | 700株 | -30% | 187,249株 | -4.1% | 1,400株 | -84.78% |
| 2022/03/11 | 日証協 | 140,000株 | -12.34% | 1,000株 | -96.34% | 195,249株 | -2.5% | 9,200株 | -46.51% |
| 2022/03/04 | 日証協 | 159,700株 | +10.83% | 27,335株 | +340.89% | 200,249株 | +8.04% | 17,201株 | +5.52% |
| 2022/02/25 | 日証協 | 144,100株 | +0.84% | 6,200株 | -88.99% | 185,348株 | +1.7% | 16,301株 | -38.5% |
※株式分割は考慮していませんのでご注意ください。
Page Top